Diane Parks

Diane Parks has extensive experience in the biotechnology and pharmaceutical sectors, currently serving on the Board of Directors for Kura Oncology, Inc., Celularity Inc., Soligenix, Inc., and Calliditas Therapeutics AB. Diane previously held directorial positions at the Lymphoma Research Foundation and TriSalus Life Sciences, and served as a member of the Board of Directors for CTI BioPharma. Prior roles include Senior Vice President and Head of US Commercial at Kite Pharma, Vice President of Marketing at Pharmacyclics, and Vice President of Sales at Amgen. Diane holds an MBA in Marketing from Georgia State University and a BS from Kansas State University.